is presenting today at the 43rd Annual J.P. Morgan Healthcare Conference. During the presentation, Chairman and CEO Michael B. Petras, Jr. will be providing an update on Sotera Health’s business ...
Expand Energy started with Outperform rating at J.P. Morgan, citing large-scale exposure to natural gas as the largest producer in the U.S. and the trend of growing natgas demand.
I am pleased to announce that Sotera Health delivered another year of top-line growth in 2024,” said Mr. Petras. “We expect full-year revenues will be approximately $1.1 billion, representing growth ...
today announced that it will participate in the J.P. Morgan 43rd Annual Healthcare Conference, January 12-16, 2025. BioUtah President and CEO, Kelvyn Cullimore, will attend on behalf of the ...
Ollie's Bargain Outlet Holdings (NASDAQ:OLLI) was one of the biggest gainers in the consumer sector on Thursday after J.P. Morgan added the stock to its Analyst Focus List on its view the ...
Morgan Stanley analyst Michael Cyprys maintained a Buy rating on Nasdaq (NDAQ – Research Report) today and set a price target of $93.00. The company’s shares closed yesterday at $78.39.
OPKO Health will present at the J.P. Morgan Healthcare Conference and host investor meetings from January 13-16, 2025. OPKO Health, Inc. announced that its management will participate in the 43rd ...
Kymera Therapeutics (KYMR) stock surged as the company outlined its 2025 outlook at the J.P. Morgan Healthcare Conference. Read more here.
A live webcast of Mr. Petras’ presentation and accompanying materials may be accessed via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay of ...
Jan. 9, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will present at the 43rd Annual J.P. Morgan Healthcare Conference ... do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter ...